Upregulated amniotic fluid cytokines and chemokines in emergency cerclage with protruding membranes

American Journal of Reproductive Immunology

Volumn 66, Issue 4, 2011, Pages 310-319

  Park, Joon Cheol ^a,b   Kim, Dong Ja ^b   Kwak kim, Joanne ^b  

^a Keimyung University   (South Korea)

^b ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

C reactive protein; Chemokine; Cytokine; Emergency cervical cerclage; Prognosis

Indexed keywords

C REACTIVE PROTEIN; CHEMOKINE; CYTOKINE; EPIDERMAL GROWTH FACTOR; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADULT; AMNION FLUID; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MARKER; EMERGENCY SURGERY; FEMALE; FETUS MEMBRANE; HUMAN; INFLAMMATION; OVERALL SURVIVAL; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; UPREGULATION; UTERINE CERVIX CERCLAGE; UTERINE CERVIX DILATATION;

ADULT; AMNIOTIC FLUID; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CERCLAGE, CERVICAL; CHORIOAMNIONITIS; CYTOKINES; EMERGENCY SERVICE, HOSPITAL; FEMALE; GESTATIONAL AGE; HUMANS; INFANT MORTALITY; INFANT, NEWBORN; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; REPUBLIC OF KOREA;

EID: 80052564384     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2011.00991.x     Document Type: Article

References (45)

1. Daskalakis G, Papantoniou N, Mesogitis S, Antsaklis A: Management of cervical insufficiency and bulging fetal membranes. Obstet Gynecol 2006; 107:221-226.
2. Mann EC, McLarn WD, Hayt DB: The physiology and clinical significance of the uterine isthmus. I. The two-stage intrauterine ballon in the diagnosis and treatment of cervical incompetence. Am J Obstet Gynecol 1961; 81:209-222.
3. Stromme WB, Haywa EW: Intrauterine fetal death in the second trimester. Am J Obstet Gynecol 1963; 85:223-233.
4. Lazar P, Gueguen S, Dreyfus J, Renaud R, Pontonnier G, Papiernik E: Multicentred controlled trial of cervical cerclage in women at moderate risk of preterm delivery. Br J Obstet Gynaecol 1984; 91:731-735.
5. Harger JH: Cerclage and cervical insufficiency: an evidence-based analysis. Obstet Gynecol 2002; 100:1313-1327.
6. Terkildsen MF, Parilla BV, Kumar P, Grobman WA: Factors associated with success of emergent second-trimester cerclage. Obstet Gynecol 2003; 101:565-569.
7. Ochi M, Ishikawa K, Itoh H, Miwa S, Fujimura Y, Kimura T, Ishizuka T, Kazeto S, Sunouchi S, Horibe N: Aggressive management of prolapsed fetal membranes earlier than 26weeks' gestation by emergent McDonald cerclage combined with amniocentesis and bladder overfilling. Nippon Sanka Fujinka Gakkai Zasshi 1994; 46:301-307.
8. Stupin JH, David M, Siedentopf JP, Dudenhausen JW: Emergency cerclage versus bed rest for amniotic sac prolapse before 27 gestational weeks. A retrospective, comparative study of 161 women. Eur J Obstet Gynecol Reprod Biol 2008; 139:32-37.
9. Olatunbosun OA, al-Nuaim L, Turnell RW: Emergency cerclage compared with bed rest for advanced cervical dilatation in pregnancy. Int Surg 1995; 80:170-174.
10. Schorr SJ, Morales WJ: Obstetric management of incompetent cervix and bulging fetal membranes. J Reprod Med 1996; 41:235-238.
11. Minakami H, Matsubara S, Izumi A, Kosuge S, Watanabe T, Iwasaki R, Sato I: Emergency cervical cerclage: relation between its success, preoperative serum level of C-reactive protein and WBC count, and degree of cervical dilatation. Gynecol Obstet Invest 1999; 47:157-161.
12. Debby A, Sadan O, Glezerman M, Golan A: Favorable outcome following emergency second trimester cerclage. Int J Gynaecol Obstet 2007; 96:16-19.
13. Roman AS, Rebarber A, Sfakianaki AK, Mulholland J, Saltzman D, Paidas MJ, Minior V, Lockwood CJ: Vaginal fetal fibronectin as a predictor of spontaneous preterm delivery in the patient with cervical cerclage. Am J Obstet Gynecol 2003; 189:1368-1373.
14. Goldenberg RL, Hauth JC, Andrews WW: Intrauterine infection and preterm delivery. N Engl J Med 2000; 342:1500-1507.
15. Tornblom SA, Klimaviciute A, Bystrom B, Chromek M, Brauner A, Ekman-Ordeberg G: Non-infected preterm parturition is related to increased concentrations of IL-6, IL-8 and MCP-1 in human cervix. Reprod Biol Endocrinol 2005; 3:39.
16. Saji F, Samejima Y, Kamiura S, Sawai K, Shimoya K, Kimura T: Cytokine production in chorioamnionitis. J Reprod Immunol 2000; 47:185-196.
17. Endres LK, Wang EY: Interleukin-6 and tumor necrosis factor alpha as predictors of success after emergent cerclage. Am J Perinatol 2004; 21:477-481.
18. Lee KY, Jun HA, Kim HB, Kang SW: Interleukin-6, but not relaxin, predicts outcome of rescue cerclage in women with cervical incompetence. Am J Obstet Gynecol 2004; 191:784-789.
19. Sakai M, Shiozaki A, Tabata M, Sasaki Y, Yoneda S, Arai T, Kato K, Yamakawa Y, Saito S: Evaluation of effectiveness of prophylactic cerclage of a short cervix according to interleukin-8 in cervical mucus. Am J Obstet Gynecol 2006; 194:14-19.
20. Weiner CP, Lee KY, Buhimschi CS, Christner R, Buhimschi IA: Proteomic biomarkers that predict the clinical success of rescue cerclage. Am J Obstet Gynecol 2005; 192:710-718.
21. Simcox R, Shennan A: Cervical cerclage: a review. Int J Surg 2007; 5:205-209.
22. Rush RW, Isaacs S, McPherson K, Jones L, Chalmers I, Grant A: A randomized controlled trial of cervical cerclage in women at high risk of spontaneous preterm delivery. Br J Obstet Gynaecol 1984; 91:724-730.
23. Final report of the Medical Research Council/Royal College of Obstetricians and Gynaecologists multicentre randomised trial of cervical cerclage. MRC/RCOG Working Party on cervical cerclage. Br J Obstet Gynaecol 1993; 100:516-523.
24. Althuisius SM, Dekker GA, Hummel P, Bekedam DJ, van Geijn HP: Final results of the Cervical Incompetence Prevention Randomized Cerclage Trial (CIPRACT): therapeutic cerclage with bed rest versus bed rest alone. Am J Obstet Gynecol 2001; 185:1106-1112.
25. Rust OA, Atlas RO, Jones KJ, Benham BN, Balducci J: A randomized trial of cerclage versus no cerclage among patients with ultrasonographically detected second-trimester preterm dilatation of the internal os. Am J Obstet Gynecol 2000; 183:830-835.
26. Guzman ER, Houlihan C, Vintzileos A, Ivan J, Benito C, Kappy K: The significance of transvaginal ultrasonographic evaluation of the cervix in women treated with emergency cerclage. Am J Obstet Gynecol 1996; 175:471-476.
27. Romero R, Gonzalez R, Sepulveda W, Brandt F, Ramirez M, Sorokin Y, Mazor M, Treadwell MC, Cotton DB: Infection and labor. VIII. Microbial invasion of the amniotic cavity in patients with suspected cervical incompetence: prevalence and clinical significance. Am J Obstet Gynecol 1992; 167:1086-1091.
28. Caruso A, Trivellini C, De Carolis S, Paradisi G, Mancuso S, Ferrazzani S: Emergency cerclage in the presence of protruding membranes: is pregnancy outcome predictable? Acta Obstet Gynecol Scand 2000; 79:265-268.
29. Hillier SL, Witkin SS, Krohn MA, Watts DH, Kiviat NB, Eschenbach DA: The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection. Obstet Gynecol 1993; 81:941-948.
30. Hirsch E, Wang H: The molecular pathophysiology of bacterially induced preterm labor: insights from the murine model. J Soc Gynecol Investig 2005; 12:145-155.
31. Ryckman KK, Williams SM, Krohn MA, Simhan HN: Genetic association of Toll-like receptor 4 with cervical cytokine concentrations during pregnancy. Genes Immun 2009; 10:636-640.
32. Ilievski V, Lu SJ, Hirsch E: Activation of toll-like receptors 2 or 3 and preterm delivery in the mouse. Reprod Sci 2007; 14:315-320.
33. Romero R, Yoon BH, Mazor M, Gomez R, Diamond MP, Kenney JS, Ramirez M, Fidel PL, Sorokin Y, Cotton D, Sehgal P: The diagnostic and prognostic value of amniotic fluid white blood cell count, glucose, interleukin-6, and gram stain in patients with preterm labor and intact membranes. Am J Obstet Gynecol 1993; 169:805-816.
34. Dubicke A, Fransson E, Centini G, Andersson E, Bystrom B, Malmstrom A, Petraglia F, Sverremark-Ekstrom E, Ekman-Ordeberg G: Pro-inflammatory and anti-inflammatory cytokines in human preterm and term cervical ripening. J Reprod Immunol 2010; 84:176-185.
35. Chwalisz K, Benson M, Scholz P, Daum J, Beier HM, Hegele-Hartung C: Cervical ripening with the cytokines interleukin 8, interleukin 1 beta and tumour necrosis factor alpha in guinea-pigs. Hum Reprod 1994; 9:2173-2181.
36. Winkler M, Rath W: The role of cytokines in the induction of labor, cervical ripening and rupture of the fetal membranes. Z Geburtshilfe Neonatol 1996; 200(Suppl 1):1-12.
37. Esplin MS, Romero R, Chaiworapongsa T, Kim YM, Edwin S, Gomez R, Mazor M, Adashi EY: Monocyte chemotactic protein-1 is increased in the amniotic fluid of women who deliver preterm in the presence or absence of intra-amniotic infection. J Matern Fetal Neonatal Med 2005; 17:365-373.
38. Proost P, Wuyts A, Van Damme J: Human monocyte chemotactic proteins-2 and -3: structural and functional comparison with MCP-1. J Leukoc Biol 1996; 59:67-74.
39. Wennerholm UB, Holm B, Mattsby-Baltzer I, Nielsen T, Platz-Christensen JJ, Sundell G, Hagberg H: Interleukin-1alpha, interleukin-6 and interleukin-8 in cervico/vaginal secretion for screening of preterm birth in twin gestation. Acta Obstet Gynecol Scand 1998; 77:508-514.
40. Romero R, Sirtori M, Oyarzun E, Avila C, Mazor M, Callahan R, Sabo V, Athanassiadis AP, Hobbins JC: Infection and labor. V. Prevalence, microbiology, and clinical significance of intraamniotic infection in women with preterm labor and intact membranes. Am J Obstet Gynecol 1989; 161:817-824.
41. Mitchell MD, Trautman MS, Dudley DJ: Cytokine networking in the placenta. Placenta 1993; 14:249-275.
42. Gotsch F, Romero R, Kusanovic JP, Erez O, Espinoza J, Kim CJ, Vaisbuch E, Than NG, Mazaki-Tovi S, Chaiworapongsa T, Mazor M, Yoon BH, Edwin S, Gomez R, Mittal P, Hassan SS, Sharma S: The anti-inflammatory limb of the immune response in preterm labor, intra-amniotic infection/inflammation, and spontaneous parturition at term: a role for interleukin-10. J Matern Fetal Neonatal Med 2008; 21:529-547.
43. Trautman MS, Collmer D, Edwin SS, White W, Mitchell MD, Dudley DJ: Expression of interleukin-10 in human gestational tissues. J Soc Gynecol Investig 1997; 4:247-253.
44. Hanna N, Bonifacio L, Weinberger B, Reddy P, Murphy S, Romero R, Sharma S: Evidence for interleukin-10-mediated inhibition of cyclo- oxygenase-2 expression and prostaglandin production in preterm human placenta. Am J Reprod Immunol 2006; 55:19-27.
45. Wang P, Wu P, Siegel MI, Egan RW, Billah MM: Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J Biol Chem 1995; 270:9558-9563.